What Is Vitreous Degeneration and What Causes It?

Vitreous degeneration is the gradual breakdown of the gel that fills the inside of your eye, turning it from a firm, clear substance into a more liquid, debris-filled one. It happens to virtually everyone as they age, typically becoming noticeable after your 40s or 50s, though certain conditions like nearsightedness or diabetes can accelerate the process. The changes produce floaters, occasional flashes of light, and measurable drops in contrast sensitivity, and while the process itself is usually harmless, it sometimes sets the stage for serious complications like retinal tears.

What the Vitreous Does and How It Breaks Down

The vitreous body is a transparent, jelly-like substance that fills roughly 80 percent of your eyeball’s interior. It is made mostly of water, with a scaffolding of collagen fibers and hyaluronic acid molecules that keep it structured. Hyaluronic acid attracts and holds water, while collagen provides the gel with physical form. In a young eye, these components are evenly distributed, keeping the vitreous optically clear so light passes through without scattering.

Degeneration begins when that scaffolding starts to fall apart. Collagen fibers, which are normally spaced evenly apart and kept separated by hyaluronic acid, begin to clump together into visible bundles. At the same time, the gel itself liquefies, a process sometimes called syneresis. Pockets of liquid form inside what was once a uniform gel. Research has shown that one driver of this liquefaction is the breakdown of hyaluronic acid by free radicals generated through a chemical reaction between sugars and proteins in the eye. In lab conditions, antioxidant enzymes and free-radical scavengers blocked this degradation, confirming that oxidative stress plays a central role in the process.¹ This is not a single dramatic event. It unfolds over years, with liquefied pockets gradually expanding and collagen clumps growing more numerous.

Those clumped collagen fibers are what you see as floaters. They cast shadows on the retina as light passes through the eye. Whether you actually perceive a floater depends on how large the clump is and how close it sits to the retina. Modeling has shown that an opacity sitting about 1.5 mm from the retina needs to be at least roughly 215 microns across to cast a complete shadow.² Smaller clumps, or clumps farther from the retina, produce only partial shadows that your brain can more easily ignore.

Why Age Is the Dominant Cause

By middle age, a substantial portion of the vitreous has typically liquefied. The exact rate varies from person to person, but by your 80s, more than half the vitreous may be liquid rather than gel. This is a normal part of aging, driven by the cumulative oxidative damage described above plus the natural decline of the structural molecules that hold the gel together.

As liquefaction progresses, the vitreous eventually pulls away from the retina. This event, called posterior vitreous detachment (PVD), is considered the most consequential stage of vitreous degeneration. It unfolds gradually in most people, starting at the edges and working inward. Researchers have mapped out stages of PVD, from early separation at the outer posterior pole of the eye, through partial and then complete detachment from the fovea (the center of sharp vision), to full separation from the optic nerve head.³ In a person with otherwise healthy eyes, PVD prevalence climbs steadily through each decade of life, reaching over 80 percent of eyes by the ninth decade.⁴

Imaging has also revealed that the earliest signs of vitreous degeneration include the formation of small fluid-filled channels and pockets within the gel, called prevascular vitreous fissures and cisterns. These fissures appear to be precursors of the larger liquid cavities that eventually cause the gel to collapse and separate from the retina.⁵

Nearsightedness as an Accelerator

If you are significantly nearsighted, your vitreous is likely degenerating faster than average. Highly myopic eyes are longer than normal, which stretches the vitreous and the connections between the vitreous and the retina. This mechanical stress appears to hasten both liquefaction and PVD. One study found that PVD may develop roughly a decade earlier in highly myopic eyes compared with eyes that have normal vision.⁴

The numbers are striking in specific age groups. Among people in their 50s, complete PVD was found in about 54 percent of highly myopic eyes compared with just 14 percent of non-highly-myopic eyes. By the 60s, the gap narrowed somewhat but remained significant, with roughly 74 percent of highly myopic eyes showing complete PVD versus 44 percent of non-highly-myopic eyes.⁶ The degree of myopia matters too: more severe nearsightedness correlates with earlier and more advanced vitreous changes.⁴

Cataract Surgery and the Vitreous

Cataract surgery is one of the most common operations in the world, and it has a well-documented effect on vitreous degeneration. Removing the natural lens changes the chemical environment inside the eye and physically disrupts the vitreous to some extent. The result is a significantly accelerated timeline for PVD. In one study, about a fifth of eyes developed PVD within just one week of surgery, and roughly a third had PVD by one month. Even after a full year, only about 41 percent of eyes still had an intact vitreous attachment.⁷

A separate study comparing operated and unoperated eyes found that the risk of progressing to complete PVD was approximately seven times higher in the operated eye within the first year after surgery.⁸ This is one reason why eye doctors counsel patients to watch for sudden increases in floaters or flashes of light after cataract surgery, since faster PVD carries a higher risk of retinal complications.

The Diabetes Connection

Diabetes affects the vitreous in a somewhat paradoxical way. Liquefaction of the vitreous gel tends to start earlier in diabetic eyes than in non-diabetic ones, likely because elevated blood sugar accelerates the same sugar-protein reactions that generate free radicals and break down hyaluronic acid. But at the same time, diabetes can strengthen the adhesion between the vitreous and the retina, delaying complete PVD even as the gel itself is deteriorating.⁹ This combination of a more liquid vitreous that remains stubbornly attached to the retina creates a damaging tug on retinal blood vessels and tissue, setting the stage for complications as diabetic eye disease progresses.

Retinal Tears and Detachment

The most feared consequence of vitreous degeneration is a retinal tear. When the vitreous separates from the retina during PVD, it usually peels away cleanly. But when the vitreous is abnormally adherent to a patch of retina, the separating gel can tug hard enough to rip the tissue. A retinal tear left untreated can allow fluid to seep behind the retina and cause a retinal detachment, which threatens permanent vision loss.

Most retinal tears happen around the time PVD occurs, but delayed tears are possible. A case report documented a retinal tear developing 21 months after the initial PVD event in a patient with myopia and a pre-existing area of retinal thinning called lattice degeneration.¹⁰ This is why people who experience a sudden burst of new floaters or persistent flashes are typically re-examined over several months even if the initial check shows no tear.

Macular Complications

The vitreous does not always separate from the macula smoothly. Sometimes it remains stuck to the central retina while pulling away everywhere else, creating persistent traction on the most vision-critical part of the eye. This situation, known as vitreomacular traction, can produce different problems depending on the size of the adhesion. A narrow, focal adhesion tends to lead to macular hole formation or small-scale swelling, while a broader adhesion is more likely to cause diffuse retinal thickening and membrane growth on the retinal surface.¹¹

Even after the vitreous does finally separate from the fovea on its own, the damage may already be done. Research has found that traction-induced injury to the inner layers of the fovea, occurring before or during the separation, can destabilize the retinal structure and predispose the eye to delayed macular hole formation.¹² In other words, the damage from incomplete vitreous separation is not always reversible once the vitreous finishes detaching.

How Vitreous Degeneration Affects Everyday Vision

Many people assume floaters are only a cosmetic annoyance. The evidence suggests otherwise. Symptomatic vitreous degeneration measurably reduces contrast sensitivity, meaning your ability to distinguish objects from their background, especially in lower light. One study found that people with symptomatic vitreous degeneration had contrast thresholds roughly 37 percent lower in bright light and about 28 percent lower in dim light compared with people without symptoms. In those who had already developed PVD, the drop in bright-light contrast was even steeper, reaching about 64 percent below normal.¹³

These findings are backed by objective measurements. Quantitative ultrasound studies have shown that the density of material floating in the vitreous correlates strongly with both contrast sensitivity scores and self-reported visual function questionnaire results.¹⁴ In practical terms, people with significant floaters often struggle with reading, driving in certain lighting conditions, and using screens, even though their standard letter-chart visual acuity may test as normal.

The Psychological Toll

The gap between how doctors traditionally view floaters and how patients experience them has been documented. Clinicians sometimes dismiss floaters as benign, and in the strictly medical sense they usually are. But research into the psychological burden tells a different story. A study comparing floater patients with controls found that floater sufferers scored significantly higher on measures of depression and perceived stress, and had higher state anxiety. The severe-discomfort group showed the greatest elevations across all psychological measures.¹⁵ This matters because the emotional weight of floaters can be self-reinforcing: heightened anxiety leads to hyperawareness, which makes the floaters feel more intrusive, which drives more anxiety. Awareness of this cycle is important for both patients and their doctors.

How Doctors Detect and Monitor Changes

For decades, the standard tool for evaluating PVD was a dilated eye exam combined with B-scan ultrasonography. These methods work but can miss early or partial separations. Newer swept-source optical coherence tomography (SS-OCT) devices have transformed the picture. Widefield SS-OCT can capture up to 23 mm of the eye’s interior in a single image, allowing detailed staging of PVD across a range of ages.¹⁶ Specialized imaging protocols that defocus the OCT into the vitreous cavity can reveal the mechanical process of vitreous separation from the macula in fine detail.¹⁷

These imaging advances matter practically. If a doctor can precisely stage PVD, they can better predict which eyes are at risk for complications and which just need monitoring. The ability to spot the early fissures and liquid pockets that precede full PVD also opens a window for tracking progression over time.⁵

Treatment Options

Most vitreous degeneration requires no treatment. The brain adapts to mild floaters over weeks to months, and many people who were initially distressed find them far less noticeable a year later. For cases where the vitreous has not separated cleanly and is pulling on the macula, pharmacological intervention exists. Ocriplasmin is a recombinant enzyme that targets fibronectin and laminin, two proteins at the junction between the vitreous and the retina, and can release vitreomacular traction without surgery.¹⁸ It is injected directly into the eye and works best in eyes with focal adhesion rather than broad traction.

For floaters that severely impair daily life, two interventional options exist: YAG laser vitreolysis, which uses laser pulses to break up or vaporize vitreous opacities, and pars plana vitrectomy, a surgical procedure that removes some or all of the vitreous gel and replaces it with saline. A Cochrane review examining these two approaches found insufficient high-quality evidence to definitively compare them, reflecting how relatively new the field of treating bothersome floaters still is.¹⁹ Vitrectomy is effective but carries risks including cataract acceleration and, rarely, retinal detachment. Laser vitreolysis is less invasive but may require multiple sessions and does not work for all types of opacities.

Antioxidant Research and Prevention

Given the role of oxidative stress in breaking down hyaluronic acid and collagen in the vitreous, researchers have explored whether antioxidants could slow vitreous degeneration. The idea has biological plausibility: the eye already maintains its own antioxidant defenses, including ascorbic acid (vitamin C), which is present in the vitreous at concentrations much higher than in the blood. A review of the evidence concluded that adequate antioxidant levels inside the vitreous may be protective against degeneration and could potentially reduce floater symptoms and other vitreoretinal problems.²⁰

The difficulty is that the vitreous is an enclosed compartment with limited blood supply, making it hard to influence through dietary supplements or systemic drugs. Whether oral antioxidants can meaningfully raise antioxidant levels inside the vitreous gel has not been conclusively demonstrated in large clinical trials. For now, the antioxidant angle remains a promising research direction rather than a proven prevention strategy. The best-supported practical steps for slowing vitreous degeneration are managing systemic risk factors like blood sugar control in diabetes, protecting the eyes from UV exposure, and being aware of the accelerated timeline if you are significantly nearsighted or have had cataract surgery.